MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Country |
 USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
123 M |
Market Cap[1] |
$ 452 M |
EBITDA (LTM) |
$ -63.6 M |
P/E (LTM) |
-7.79 |
P/S (LTM) |
42.14 |
EPS (LTM) |
-0.48 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Assembly Biosciences
ASMB
|
$ 28.46 | 3.45 % | $ 319 M | Nasdaq Global Select Market,SPB | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 221.88 | -0.87 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Axsome Therapeutics
AXSM
|
$ 156.92 | -1.23 % | $ 7.81 B | Nasdaq Global Market,SPB | USA |
 |
Galera Therapeutics
GRTX
|
- | -32.59 % | $ 7.61 M | Nasdaq Global Market | USA |
 |
Pharming Group N.V.
PHAR
|
$ 15.36 | -0.71 % | $ 7.59 B | Nasdaq Global Select Market |  Niderland |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.37 | -4.2 % | $ 350 M | Nasdaq Global Select Market |  Britain |
 |
Kamada Ltd.
KMDA
|
$ 8.5 | -1.39 % | $ 260 M | Nasdaq Global Select Market |  Israel |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Benitec Biopharma
BNTC
|
$ 10.98 | -4.52 % | $ 452 M | Nasdaq Capital Market | USA |
 |
Inventiva S.A.
IVA
|
$ 5.78 | -4.3 % | $ 138 M | Nasdaq Global Market | France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Compugen Ltd.
CGEN
|
$ 2.09 | -0.95 % | $ 195 M | Nasdaq Global Market,SPB | Israel |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 1.21 | -3.97 % | $ 71.5 M | Nasdaq Global Market | Britain |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
PainReform Ltd.
PRFX
|
$ 2.28 | -0.44 % | $ 1.03 M | Nasdaq Capital Market | Israel |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
|
Foghorn Therapeutics
FHTX
|
$ 5.0 | 2.25 % | $ 315 M | Nasdaq Global Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
AbCellera Biologics
ABCL
|
$ 3.4 | -3.68 % | $ 1.02 B | Nasdaq Global Select Market | Canada |
 |
BioMarin Pharmaceutical
BMRN
|
$ 54.13 | -1.64 % | $ 10.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Curis
CRIS
|
$ 0.77 | 1.89 % | $ 4.86 M | Nasdaq Global Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Coherus BioSciences
CHRS
|
$ 1.52 | -5.59 % | $ 178 M | Nasdaq Global Market | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Burford Capital Limited
BUR
|
$ 7.7 | -5.87 % | $ 1.29 B | NYSE | Britain |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Cellectis S.A.
CLLS
|
$ 3.34 | -4.02 % | $ 116 M | Nasdaq Global Market | France |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.24 | -2.97 % | $ 704 M | Nasdaq Global Select Market | Canada |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 1.8 | -1.1 % | $ 120 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Cabaletta Bio
CABA
|
$ 2.94 | -3.29 % | $ 3.43 M | Nasdaq Global Select Market | USA |
 |
Iterum Therapeutics
ITRM
|
$ 0.16 | -5.45 % | $ 3.15 M | Nasdaq Global Select Market |  Irlanda |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.